WikiTrademarks - Search, analyse, and monitor trademark applications.

Trademark: RELIAMPI

Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io

Tweet this

Track updates on RELIAMPI

Proof of use for RELIAMPI

We do not have any records of a proof of use for RELIAMPI at this moment.

Click here to add a proof of use for RELIAMPI

Possible trademark infringements of RELIAMPI

Basic Information about RELIAMPI

Serial Number
86487814
Filing Date
22 Dec 2014
Registration Number
4891595
Registration Date
26 Jan 2016
Mark Drawing Code
4

Classifications

Declare the trademark use of RELIAMPI on the blockchain with WikiTrademarks.io.

First use of RELIAMPI anywhere
No first use declared yet.
First use in commerce
There is no first use of this trademark in commerce detected yet.
Status Code
2
International Code
005
US Codes
006; 018; 044; 046; 051; 052

Who owns RELIAMPI?

1. AstraZeneca AB Södertälje

2. AstraZeneca AB Södertälje

3. AstraZeneca AB Södertälje

Correspondent

Cara M. Kearney
AstraZeneca Pharmaceuticals LP
1800 Concord Pike, A2C
Wilmington DE 19850-5437

Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io

Tweet this

Track updates on RELIAMPI